(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202303 | 202203 | % Var | 202303 | 202203 | % Var | 202303 | 202203 | % Var | |
| Sales | 28362.70 | 28553.90 | -0.67 | 112588.30 | 117716.70 | -4.36 | 112588.30 | 117716.70 | -4.36 |
| Other Income | 553.00 | 161.50 | 242.41 | 912.60 | 1504.20 | -39.33 | 912.60 | 1504.20 | -39.33 |
| PBIDT | 3174.80 | 5171.50 | -38.61 | 11739.20 | 4261.30 | 175.48 | 11739.20 | 4261.30 | 175.48 |
| Interest | 294.40 | 245.80 | 19.77 | 984.40 | 734.70 | 33.99 | 984.40 | 734.70 | 33.99 |
| PBDT | 2880.40 | 4925.70 | -41.52 | 10754.80 | 3526.60 | 204.96 | 10754.80 | 3526.60 | 204.96 |
| Depreciation | 1462.00 | 1310.20 | 11.59 | 5483.40 | 5141.90 | 6.64 | 5483.40 | 5141.90 | 6.64 |
| PBT | 1418.40 | 3615.50 | -60.77 | 5271.40 | -1615.30 | -426.34 | 5271.40 | -1615.30 | -426.34 |
| TAX | 228.30 | 3974.40 | -94.26 | 1019.30 | 271.70 | 275.16 | 1019.30 | 271.70 | 275.16 |
| Deferred Tax | -25.90 | 3419.40 | -100.76 | 60.40 | -306.30 | -119.72 | 60.40 | -306.30 | -119.72 |
| PAT | 1190.10 | -358.90 | -431.60 | 4252.10 | -1887.00 | -325.34 | 4252.10 | -1887.00 | -325.34 |
| Equity | 910.00 | 909.00 | 0.11 | 910.00 | 909.00 | 0.11 | 910.00 | 909.00 | 0.11 |
| PBIDTM(%) | 11.19 | 18.11 | -38.20 | 10.43 | 3.62 | 188.03 | 10.43 | 3.62 | 188.03 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: